Mesenchymal stem cells and cardiac repair

被引:90
作者
Nesselmann, Catharina [1 ]
Ma, Nan [1 ]
Bieback, Karen [2 ]
Wagner, Wolfgang [3 ]
Ho, Anthony [3 ]
Konttinen, Yrjo T. [4 ]
Zhang, Hao [5 ,6 ]
Hinescu, Mihail E. [7 ,8 ]
Steinhoff, Gustav [1 ]
机构
[1] Univ Rostock, Dept Cardiac Surg, D-18057 Rostock, Germany
[2] Heidelberg Univ, Inst Transfus Med & Immunol, Med Fac Mannheim, German Red Cross Blood Donor Serv Baden Wurttembe, D-6900 Heidelberg, Germany
[3] Heidelberg Univ, Med Klin 5, D-6900 Heidelberg, Germany
[4] Biomedicum Helsinki, Helsinki, Finland
[5] Chinese Acad Med Sci, Cardiovasc Inst, Beijing, Peoples R China
[6] Chinese Acad Med Sci, Fuwai Hosp, Beijing, Peoples R China
[7] Carol Davila Univ Med & Pharm, Dept Cellular & Mol Med, Bucharest, Romania
[8] Victor Babes Natl Inst Pathol, Bucharest, Romania
关键词
mesenchymal stem cells; ICLCs; regenerative medicine; heart muscle; repair mechanisms; ex vivo cell manipulation;
D O I
10.1111/j.1582-4934.2008.00457.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Accumulating clinical and experimental evidence indicates that mesenchymal stem cells (MSCs) are promising cell types in the treatment of cardiac dysfunction. They may trigger production of reparative growth factors, replace damaged cells and create an environment that favours endogenous cardiac repair. However, identifying mechanisms which regulate the role of MSCs in cardiac repair is still at work. To achieve the maximal clinical benefits, ex vivo manipulation can further enhance MSC therapeutic potential. This review focuses on the mechanism of MSCs in cardiac repair, with emphasis on ex vivo manipulation.
引用
收藏
页码:1795 / 1810
页数:16
相关论文
共 138 条
[101]   FGF-2 controls the differentiation of resident cardiac precursors into functional cardiomyocytes [J].
Rosenblatt-Velin, N ;
Lepore, MG ;
Cartoni, C ;
Beermann, F ;
Pedrazzini, T .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1724-1733
[102]   Cardiac cell therapy - Mixed results from mixed cells [J].
Rosenzweig, Anthony .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (12) :1274-1277
[103]   Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells [J].
Rosova, Ivana ;
Dao, Mo ;
Capoccia, Ben ;
Link, Daniel ;
Nolta, Jan A. .
STEM CELLS, 2008, 26 (08) :2173-2182
[104]   Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells [J].
Ruester, Brigitte ;
Goettig, Stephan ;
Ludwig, Ralf J. ;
Bistrian, Roxana ;
Mueller, Stefanie ;
Seifried, Erhard ;
Gille, Jens ;
Henschler, Reinhard .
BLOOD, 2006, 108 (12) :3938-3944
[105]   Human bronchial fibroblasts exhibit a mesenchymal stem cell phenotype and multilineage differentiating potentialities [J].
Sabatini, F ;
Petecchia, L ;
Tavian, M ;
de Villeroche, VJ ;
Rossi, GA ;
Brouty-Boyé, D .
LABORATORY INVESTIGATION, 2005, 85 (08) :962-971
[106]   Costameres, focal adhesions, and cardiomyocyte mechanotransduction [J].
Samarel, AM .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2005, 289 (06) :H2291-H2301
[107]  
Schallmoser K, 2007, TRANSFUSION, V47, p28A
[108]   Early improvement in cardiac tissue perfusion due to mesenchymal stem cells [J].
Schuleri, Karl H. ;
Amado, Luciano C. ;
Boyle, Andrew J. ;
Centola, Marco ;
Saliaris, Anastasios P. ;
Gutman, Matthew R. ;
Hatzistergos, Konstantinos E. ;
Oskouei, Behzad N. ;
Zimmet, Jeffrey M. ;
Young, Randell G. ;
Heldman, Alan W. ;
Lardo, Albert C. ;
Hare, Joshua M. .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2008, 294 (05) :H2002-H2011
[109]   A role for bone morphogenetic proteins in the induction of cardiac myogenesis [J].
Schultheiss, TM ;
Burch, JBE ;
Lassar, AB .
GENES & DEVELOPMENT, 1997, 11 (04) :451-462
[110]   Cardiac myocyte-specific excision of the β1 integrin gene results in myocardial fibrosis and cardiac failure [J].
Shai, SY ;
Harpf, AE ;
Babbitt, CJ ;
Jordan, MC ;
Fishbein, MC ;
Chen, J ;
Omura, M ;
Leil, TA ;
Becker, KD ;
Jiang, MH ;
Smith, DJ ;
Cherry, SR ;
Loftus, JC ;
Ross, RS .
CIRCULATION RESEARCH, 2002, 90 (04) :458-464